Quantum leaps in treatment of high-risk breast cancer? Prove it!
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1488-1493
- https://doi.org/10.1016/0959-8049(93)90027-d
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A meta-analysis of reported correlations between prognostic factors in breast cancer: Does axillary lymph node metastasis represent biology or chronology?European Journal of Cancer and Clinical Oncology, 1991
- Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.Journal of Clinical Oncology, 1989
- Relation of tumor size, lymph node status, and survival in 24,740 breast cancer casesCancer, 1989
- Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.Journal of Clinical Oncology, 1988
- Development and Use of a Natural History Data Base of Breast Cancer StudiesAmerican Journal of Clinical Oncology, 1987
- Adjuvant systemic therapy for resectable breast cancer.Journal of Clinical Oncology, 1985
- Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failureCancer, 1984
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- Management and survival of female breast cancer: Results of a national survey by the American college of surgeonsCancer, 1980